Inbrija

Active Ingredient(s): Levodopa
FDA Approved: * December 21, 2018
Pharm Company: * ACORDA
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Inbrija Overview

l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Fu...

Read more Inbrija Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/L-DOPA

Recent Inbrija Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Levodopa
  • Capsule: 100mg, 250mg, 500mg
  • Powder: 42mg
  • Tablet: 100mg, 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Inbrija: (1 result)

Sorted by National Drug Code
  • 10144-342 Inbrija 42 mg Respiratory (Inhalation) Capsule by Acorda Therapeutics, Inc.

Other drugs which contain Levodopa or a similar ingredient: (13 results)